Sweden Pharmaceutical Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Swedish Pharmaceutical Companies and the Market is segmented by ATC/Therapeutic Class (Digestive Organs and Metabolism, Blood and Blood Forming Organs, Heart and Circulation, Skin Preparation, Urinary and Genital Organs and Sex Hormones, Systemic Hormonal Preparations, Excluding Sex Hormone and Insulin, Anti-infectives for Systemic Use, Tumors and Disorders of Immune System, Musculoskeletal System, Nervous System, Antiparasitic Products, Insecticides and Repellents, Respiratory System and Others), Drug Type (Branded and Generic), and Prescription Type (Prescription Drugs (Rx) and OTC Drugs). The Market values are Provided (in USD million) for the above segments.

Sweden Pharmaceutical Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Sweden Pharmaceutical Industry Overview

The Sweden pharmaceutical market is highly competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Some of the key companies that are currently dominating the market are AbbVie Inc., Merck & Co., Inc., Amgen Inc., Pfizer Inc., and GlaxoSmithKline plc.

Sweden Pharmaceutical Market Leaders

  1. Amgen Inc.

  2. Pfizer Inc.

  3. Novartis International AG

  4. Orifarm Group A/S

  5. Merck & Co., Inc.

  6. *Disclaimer: Major Players sorted in no particular order
AbbVie Inc., Merck & Co., Inc., Amgen Inc., Pfizer Inc., and GlaxoSmithKline plc.

Sweden Pharmaceutical Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?